Outlook Therapeutics (OTLK) Return on Sales [ROS] (2015 - 2026)
Outlook Therapeutics' Return on Sales [ROS] was -4555.19% in fiscal Q2 2026 (quarter ended Mar 31, 2026), down 90.10 percentage points from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Return on Sales [ROS] (2015 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Return on Sales [ROS] at Outlook Therapeutics came in at -4744.25%.
- Quarterly Return on Sales [ROS] has moved between -138629.87% (fiscal Q1 2025) and -1046.20% (fiscal Q3 2025) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last four quarters, with an average year-over-year change of +1140.55 percentage points.
- Per Business Quant data, OTLK's Return on Sales [ROS] in the three fiscal quarters before Q2 2026 was -4465.09% (Q1 2026), -4880.02% (Q4 2025) and -1046.20% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | -124.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -124.26% |
| Mar 31, 2026 | -11,006.82% |
| Dec 31, 2025 | -1,116.38% |
| Sep 30, 2025 | -4,880.02% |
| Jun 30, 2025 | -1,046.20% |
| Dec 31, 2024 | -138,629.87% |
| Jun 30, 2024 | -5,636.10% |
| Dec 31, 2023 | -5,398.42% |
| Sep 30, 2023 | -4,188.40% |
| Jun 30, 2023 | -4,675.07% |
| Mar 31, 2023 | -4,002.79% |
| Sep 30, 2021 | -11,212.71% |
| Dec 31, 2020 | -819.07% |
| Sep 30, 2020 | -616.61% |
| Jun 30, 2020 | -595.62% |
| Sep 30, 2019 | -216.83% |
| Jun 30, 2019 | -966.72% |
| Mar 31, 2019 | -1,201.86% |
| Dec 31, 2018 | -960.78% |
| Sep 30, 2018 | -1,608.21% |
API Access
Outlook Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();